Corcept Therapeutics Inc. diskutieren
Corcept Therapeutics Inc.
WKN: 529882 / Symbol: CORT / Name: Corcept / Aktie / Pharmazeutika / Small Cap /
99,26 €
-3,43 %
Corcept Therapeutics (CORT) had its "buy" rating reaffirmed by HC Wainwright.
Ratings data for CORT provided by MarketBeat
Corcept Therapeutics (CORT) was upgraded by Truist Financial Corporation to "strong-buy".
Ratings data for CORT provided by MarketBeat
Corcept Therapeutics (CORT) had its price target raised by HC Wainwright from $95.00 to $165.00. They now have a "buy" rating on the stock.
Ratings data for CORT provided by MarketBeat
Corcept Therapeutics (CORT) had its "overweight" rating reaffirmed by Piper Sandler. They now have a $165.00 price target on the stock, up from $88.00.
Ratings data for CORT provided by MarketBeat


Neueste Beiträge
Citigroup_Inc_ in WAVE Life Sciences Ltd diskutieren